Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19307740

Download in:

View as

General Info

PMID
19307740